Eli Lilly Canada Inc. et al. v. Novopharm Ltd., (2010) 405 N.R. 1 (FCA)
Linked as:
Extract
Eli Lilly Canada Inc. et al. v. Novopharm Ltd., (2010) 405 N.R. 1 (FCA)
No longer available (Autolink)
See the full content of this document
This document cites
- Sanofi-Synthelabo Canada Inc. et al. v. Apotex Inc. et al., (2008) 381 N.R. 125 (SCC)
- Pfizer Canada Inc. et al. v. Canada (Minister of Health) et al., (2007) 364 N.R. 396 (Motion)
- Apotex Inc. v. Bristol-Myers Squibb Co. et al., 2007 FCA 379
- Pfizer Canada Inc. et al. v. Canada (Minister of Health) et al., (2006) 351 N.R. 189 (FCA)
- Janssen-Ortho Inc. et al. v. Apotex Inc. et al., (2009) 392 N.R. 71 (FCA)
